Home › Blood Cancers › Georgia › Atlanta
Blood Cancers clinical trials in Atlanta, GA
12 studies for Blood Cancers are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 2
- Emory University Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- Winship Cancer Institute - Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Atlanta VA Medical Center, Decatur · 6 mi away
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Emory Healthcare - The Emory Clinic, Atlanta
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RecruitingPhase 1
- Emory Winship Cancer Institute, Atlanta
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
RecruitingPhase 2
- Northside Hospital, Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RecruitingPhase 1/2
- Emory Winship Cancer Institute, Atlanta
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
RecruitingObservational study
- Caitlin Guzowski, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Emory Healthcare - The Emory Clinic, Atlanta
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RecruitingPhase 1/2
- Emory University Hospital, Atlanta
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Healthcare of Atlanta, Emory University, Atlanta
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Philadelphia, PA14 studies
- Edison, NJ14 studies
- Nashville, TN13 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.